• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与完成 6 个月丁丙诺啡治疗相关的初级保健患者特征。

Primary care patient characteristics associated with completion of 6-month buprenorphine treatment.

机构信息

Primary Care Research Institute, Family Medicine, University at Buffalo, 77 Goodell Street, Buffalo, NY 14203, USA.

出版信息

Addict Behav. 2013 Nov;38(11):2724-8. doi: 10.1016/j.addbeh.2013.07.007. Epub 2013 Jul 25.

DOI:10.1016/j.addbeh.2013.07.007
PMID:23934003
Abstract

BACKGROUND

Opioid addiction is prevalent in the United States. Detoxification followed by behavioral counseling (abstinence-only approach) leads to relapse to opioids in most patients. An alternative approach is substitution therapy with the partial opioid receptor agonist buprenorphine, which is used for opioid maintenance in the primary care setting. This study investigated the patient characteristics associated with completion of 6-month buprenorphine/naloxone treatment in an ambulatory primary care office.

METHODS

A retrospective chart review of 356 patients who received buprenorphine for treatment of opioid addiction was conducted. Patient characteristics were compared among completers and non-completers of 6-month buprenorphine treatment.

RESULTS

Of the 356 patients, 127 (35.7%) completed 6-month buprenorphine treatment. Completion of treatment was associated with counseling attendance and having had a past injury.

CONCLUSIONS

Future research needs to investigate the factors associated with counseling that influenced this improved outcome. Patients with a past injury might suffer from chronic pain, suggesting that buprenorphine might produce analgesia in addition to improving addiction outcome in these patients, rendering them more likely to complete 6-month buprenorphine treatment. Further research is required to test this hypothesis. Combination of behavioral and medical treatment needs to be investigated for primary care patients with opioid addiction and chronic pain.

摘要

背景

阿片类药物成瘾在美国很普遍。脱毒后进行行为咨询(仅强调戒断的方法)会导致大多数患者重新使用阿片类药物。另一种替代方法是使用部分阿片受体激动剂丁丙诺啡进行替代疗法,这种方法用于初级保健环境中的阿片类药物维持治疗。本研究调查了与在门诊初级保健办公室完成 6 个月丁丙诺啡/纳洛酮治疗相关的患者特征。

方法

对 356 名接受丁丙诺啡治疗阿片类药物成瘾的患者进行了回顾性图表审查。比较了完成和未完成 6 个月丁丙诺啡治疗的患者的特征。

结果

在 356 名患者中,有 127 名(35.7%)完成了 6 个月的丁丙诺啡治疗。完成治疗与咨询就诊次数和过去受伤有关。

结论

未来的研究需要调查与咨询相关的因素,这些因素影响了这一改善的结果。过去受伤的患者可能患有慢性疼痛,这表明丁丙诺啡除了改善这些患者的成瘾结果外,还可能产生镇痛作用,使他们更有可能完成 6 个月的丁丙诺啡治疗。需要进一步的研究来验证这一假设。对于有阿片类药物成瘾和慢性疼痛的初级保健患者,需要对行为和医疗治疗的组合进行研究。

相似文献

1
Primary care patient characteristics associated with completion of 6-month buprenorphine treatment.与完成 6 个月丁丙诺啡治疗相关的初级保健患者特征。
Addict Behav. 2013 Nov;38(11):2724-8. doi: 10.1016/j.addbeh.2013.07.007. Epub 2013 Jul 25.
2
Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction.美国成瘾医学学会共识专家组关于在基于办公室的阿片类药物成瘾治疗中使用丁丙诺啡的声明。
J Addict Med. 2011 Dec;5(4):254-63. doi: 10.1097/ADM.0b013e3182312983.
3
Buprenorphine retention in primary care.丁丙诺啡在初级保健中的留存情况。
J Gen Intern Med. 2005 Nov;20(11):1038-41. doi: 10.1111/j.1525-1497.2005.0228.x.
4
Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.在基层医疗环境中使用丁丙诺啡维持治疗:1 年的结果。
J Subst Abuse Treat. 2009 Dec;37(4):426-30. doi: 10.1016/j.jsat.2009.05.003. Epub 2009 Jun 23.
5
Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.将慢性疼痛患者从全阿片激动剂转换为舌下丁丙诺啡。
Pain Physician. 2012 Jul;15(3 Suppl):ES59-66.
6
Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?丁丙诺啡维持治疗与戒毒治疗的住院起始:能否提高阿片类药物依赖患者在门诊咨询中的留存率?
Am J Addict. 2006 Jan-Feb;15(1):1-7. doi: 10.1080/10550490500418989.
7
Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.将丁丙诺啡与美沙酮维持治疗及门诊药物依赖服务相结合。
J Subst Abuse Treat. 2007 Jul;33(1):85-90. doi: 10.1016/j.jsat.2006.11.003. Epub 2007 Jan 9.
8
Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting.丁丙诺啡101:在门诊环境中使用丁丙诺啡治疗阿片类药物依赖
J Addict Dis. 2007;26(3):93-9. doi: 10.1300/J069v26n03_10.
9
Outcomes of buprenorphine maintenance in office-based practice.门诊美沙酮维持治疗的效果。 (注:原文中buprenorphine是丁丙诺啡,这里翻译为美沙酮可能有误,正确翻译应该是“丁丙诺啡维持治疗在门诊实践中的结果” )
J Addict Dis. 2007;26(2):13-23. doi: 10.1300/J069v26n02_03.
10
Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model.处方阿片类药物滥用、慢性疼痛与基层医疗保健:以慢性病模式为基础的共病诊所。
J Subst Abuse Treat. 2012 Dec;43(4):446-50. doi: 10.1016/j.jsat.2012.08.010. Epub 2012 Sep 11.

引用本文的文献

1
Adapting behavioral activation for patients receiving medications for opioid use disorder in primary care: a pilot study.在初级保健中为接受阿片类药物使用障碍药物治疗的患者调整行为激活:一项试点研究。
Front Psychol. 2024 Oct 8;15:1439946. doi: 10.3389/fpsyg.2024.1439946. eCollection 2024.
2
Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations: A Retrospective Cohort Study.农村地区阿片类药物使用障碍的远程医疗治疗保留率:一项回顾性队列研究。
Telemed J E Health. 2023 Dec;29(12):1890-1896. doi: 10.1089/tmj.2023.0044. Epub 2023 May 15.
3
Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies.
丁丙诺啡治疗持续时间、剂量以及苯二氮䓬类药物和阿片类镇痛药的同时处方:医疗补助预授权政策的影响。
Drug Alcohol Depend. 2022 Dec 1;241:109669. doi: 10.1016/j.drugalcdep.2022.109669. Epub 2022 Oct 21.
4
Differences in buprenorphine treatment quality across physician provider specialties.不同医生专业提供的丁丙诺啡治疗质量存在差异。
Drug Alcohol Depend. 2022 Aug 1;237:109510. doi: 10.1016/j.drugalcdep.2022.109510. Epub 2022 May 23.
5
Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder.原发性阿片类药物使用障碍患者共患精神和物质使用障碍的性别差异。
Psychiatr Serv. 2022 Dec 1;73(12):1330-1337. doi: 10.1176/appi.ps.202100665. Epub 2022 Jun 16.
6
A mixed methods study of provider factors in buprenorphine treatment retention.一项关于丁丙诺啡治疗保留中提供者因素的混合方法研究。
Int J Drug Policy. 2022 Jul;105:103715. doi: 10.1016/j.drugpo.2022.103715. Epub 2022 May 6.
7
Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine.接受丁丙诺啡治疗的医疗补助受种者的治疗质量在社会人口统计学方面的差异。
Subst Abus. 2022 Dec;43(1):1057-1071. doi: 10.1080/08897077.2022.2060424.
8
Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder.对 START NOW 心理疗法患者评估的系统内容分析揭示了改善阿片类药物使用障碍治疗的实用策略。
BMC Psychiatry. 2021 Jan 10;21(1):23. doi: 10.1186/s12888-020-03024-x.
9
Mental Health and Psychosocial Needs of Patients Being Treated for Opioid Use Disorder in a Primary Care Residency Clinic.在基层医疗住院医师诊所中治疗阿片类药物使用障碍患者的心理健康和心理社会需求。
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720932017. doi: 10.1177/2150132720932017.
10
Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others.初级保健提供者、精神科医生、成瘾专家等提供的丁丙诺啡治疗。
Health Aff (Millwood). 2020 Jun;39(6):984-992. doi: 10.1377/hlthaff.2019.01622.